National reimbursement for drugs is mainly regulated by the joint federal committee (G-BA) in Germany. However, when it comes to the management and organization of regional drug budgets and the controlling mechanisms the Association of Statutory Physicians (KVs) are a main stakeholder. Various tools exist which also vary between German regions and could have a positive or negative impact on market uptake. The regional specifics will be discussed between Dr. Stefan Walzer (MArS) and Dr. Mathias Flume (KV Westphalia-Lippe).

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.